c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation - PubMed (original) (raw)

c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation

J H Miner et al. Mol Cell Biol. 1991 May.

Abstract

In vertebrate development, a prominent feature of several cell lineages is the coupling of cell cycle regulation with terminal differentiation. We have investigated the basis of this relationship in the skeletal muscle lineage by studying the effects of the proliferation-associated regulator, c-myc, on the differentiation of MyoD-initiated myoblasts. Transient cotransfection assays in NIH 3T3 cells using MyoD and c-myc expression vectors demonstrated c-myc suppression of MyoD-initiated differentiation. A stable cell system was also developed in which MyoD expression was constitutive, while myc levels could be elevated conditionally. Induction of this conditional c-myc suppressed myogenesis effectively, even in the presence of MyoD. c-myc suppression also prevented up-regulation of a relative of MyoD, myogenin, which is normally expressed at the onset of differentiation in all muscle cell lines examined and may be essential for differentiation. Additional experiments tested whether failure to differentiate in the presence of myc could be overcome by providing myogenin ectopically. Cotransfection of c-myc with myogenin, MyoD, or a mixture of myogenin and MyoD showed that neither myogenin alone nor myogenin plus MyoD together could bypass the c-myc block. The effects of c-myc were further dissected by showing that c-myc can inhibit differentiation independently of Id, a negative regulator of muscle differentiation. These results lead us to propose that c-myc and Id constitute independent negative regulators of muscle differentiation, while myogenin and any of the other three related myogenic factors (MyoD, Myf-5, and MRF4/herculin/Myf-6) act as positive regulators.

PubMed Disclaimer

Cited by

The Popeye Domain Containing Genes and their Function in Striated Muscle.
Schindler RF, Scotton C, French V, Ferlini A, Brand T. Schindler RF, et al. J Cardiovasc Dev Dis. 2016 Jun 15;3(2):22. doi: 10.3390/jcdd3020022. J Cardiovasc Dev Dis. 2016. PMID: 27347491 Free PMC article.
Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.
Zentella A, Massagué J. Zentella A, et al. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5176-80. doi: 10.1073/pnas.89.11.5176. Proc Natl Acad Sci U S A. 1992. PMID: 1594628 Free PMC article.
DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
Johnson JE, Birren SJ, Saito T, Anderson DJ. Johnson JE, et al. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3596-600. doi: 10.1073/pnas.89.8.3596. Proc Natl Acad Sci U S A. 1992. PMID: 1314394 Free PMC article.
Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin.
Johnston LA, Tapscott SJ, Eisen H. Johnston LA, et al. Mol Cell Biol. 1992 Nov;12(11):5123-30. doi: 10.1128/mcb.12.11.5123-5130.1992. Mol Cell Biol. 1992. PMID: 1328872 Free PMC article.
Further characterization of BC3H1 myogenic cells reveals lack of p53 activity and underexpression of several p53 regulated and extracellular matrix-associated gene products.
Sharp SB, Villalvazo M, Huang M, Gonzalez R, Alarcon I, Bahamonde M, D'Agostin DM, Damle S, Espinosa A, Han SJ, Liu J, Navarro P, Salguero H, Son J, Vu S. Sharp SB, et al. In Vitro Cell Dev Biol Anim. 2002 Jul-Aug;38(7):382-93. doi: 10.1290/1071-2690(2002)038<0382:FCOBMC>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2002. PMID: 12534338

References

1. Mol Cell Biol. 1984 Dec;4(12):2929-31 - PubMed
1. Mol Cell Biol. 1987 Oct;7(10):3554-60 - PubMed
1. Mol Cell Biol. 1987 May;7(5):1973-7 - PubMed
1. Cell. 1987 Dec 24;51(6):987-1000 - PubMed
1. J Cell Biol. 1987 Aug;105(2):949-56 - PubMed

c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation - PubMed (original) (raw)